Business & Finance
Alnylam Pharmaceuticals Inc intends $125m public offering
15 January 2013 - RNAi therapeutics company Alnylam Pharmaceuticals Inc (NasdaqGS :ALNY) revealed on Monday plans to commence an $125m underwritten public offering of shares of its common stock. The ...
Watson Pharmaceuticals Inc announces Investor Meeting on 25 January 2013
14 January 2013 - Pharmaceutical company Watson Pharmaceuticals Inc (NYSE:WPI) said on Friday that it will host an Investor Meeting on 25 January 2013 at 8:00 EST in New York. The company stated that...
Covidien’s acquisition of CV Ingenuity complete
11 January 2013 - Covidien (NYSE:COV), a provider of healthcare products, announced on Thursday the completion of the acquisition of CV Ingenuity. Financial details of the acquisition were not disclo...
Intellipharmaceutics International Inc concludes $1.5m convertible debenture financing
11 January 2013 - Pharmaceutical company Intellipharmaceutics International Inc (TSX:I) reported on Thursday the launch of a non-brokered private placement with $1.5m aggregate principal amount of uns...
SANUWAVE Health Inc’s net loss narrows to USD1.447m in Q3 2012
15 November 2012 - Regenerative medicine company SANUWAVE Health Inc (OTC BB:SNWV) stated on Wednesday ia net loss of USD1.447m (USD0.07 per share) for the three months ended 30 September 2012. This ...
Nymox Pharmaceutical Corporation posts lower net loss of USD0.04 per share for Q3 2012
15 November 2012 - Therapeutics and diagnostics company Nymox Pharmaceutical Corporation (NasdaqCM:NYMX) revealed on Wednesday a net loss of USD1.24m, or USD0.04 per share, for the third quarter of 20...